MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 214 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q2 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $59,020 | +42.0% | 5,902 | +76.5% | 0.00% | – |
| Q2 2023 | $41,551 | -37.1% | 3,344 | -29.1% | 0.00% | – |
| Q1 2023 | $66,090 | +8.9% | 4,718 | +12.5% | 0.00% | – |
| Q4 2022 | $60,703 | -32.6% | 4,194 | +19.3% | 0.00% | – |
| Q3 2022 | $90,000 | +2.3% | 3,516 | +13.7% | 0.00% | – |
| Q2 2022 | $88,000 | -90.5% | 3,091 | -88.2% | 0.00% | -100.0% |
| Q1 2022 | $928,000 | +736.0% | 26,286 | +894.6% | 0.00% | – |
| Q4 2021 | $111,000 | -13.3% | 2,643 | +0.8% | 0.00% | – |
| Q3 2021 | $128,000 | -90.5% | 2,621 | -91.9% | 0.00% | -100.0% |
| Q2 2021 | $1,347,000 | +848.6% | 32,292 | +709.3% | 0.00% | – |
| Q1 2021 | $142,000 | +167.9% | 3,990 | +110.8% | 0.00% | – |
| Q4 2020 | $53,000 | – | 1,893 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $1,064,105,000 | 26.99% |
| Ghisallo Capital Management LLC | 1,250,000 | $61,350,000 | 2.33% |
| Beck Bode, LLC | 160,064 | $7,856,000 | 2.19% |
| Select Equity Group, L.P. | 12,122,011 | $594,948,300,000 | 2.00% |
| Pinz Capital Management, LP | 83,603 | $4,103,000 | 1.86% |
| Monashee Investment Management LLC | 185,000 | $9,080,000 | 1.68% |
| Ownership Capital B.V. | 2,717,559 | $133,378,000 | 1.51% |
| Eversept Partners, LP | 327,810 | $16,088,915 | 1.12% |
| Parkman Healthcare Partners LLC | 90,000 | $4,417,000 | 1.12% |
| Connacht Asset Management LP | 28,569 | $1,402,000 | 0.91% |